Enveric Biosciences, Inc. (ENVB) Misses Q2 EPS by 100c
Tweet
Share
E-mailGet Alerts ENVB Hot Sheet
Join SI Premium – FREE
Enveric Biosciences, Inc. (NASDAQ: ENVB) reported Q2 EPS of ($3.04), $1.00 worse than the analyst estimate of ($2.04).
For earnings history and earnings-related data on Enveric Biosciences, Inc. (ENVB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Benchmark Reiterates Buy Rating on Marvell (MRVL) Following Earnings
- Hub Group faces credibility test as Q2 report looms Sept. 1
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
